Lutz Konrad

ORCID: 0000-0001-5878-3050 · 42 papers in corpus
lab-animal 2018
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719118811643

Claudins are the major components of tight junctions and are often deregulated in human cancer, permitting escape of cancer cells along with the acquisition of invasive properties. Similarly, endometrial cells also show invasive capabilitie…

lab-animal 2018
Biochimica et biophysica acta. Molecular and cell biology of lipids ·doi:10.1016/j.bbalip.2018.08.013

Extracellular lysophosphatidic acid (LPA) and the G-protein-coupled LPA receptors (LPAR) are involved in cell migration and invasion and found in the human endometrium. However, underlying mechanisms resulting in cellular invasion have been…

other 2018
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719118756745

Epithelial-mesenchymal transition (EMT) is characterized by the loss of epithelial and acquisition of mesenchymal cell characteristics. Our aim was to assess the epithelial phenotype in the pathogenesis of endometriosis with epithelial and …

2017
other 2016
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719116641756

Clusterin (CLU) is expressed in tissues and body fluids and is altered in some pathologies. In endometriosis, a noninvasive test is still lacking, thus, we analyzed CLU in mucus samples of patients. Additionally, we investigated localizatio…

lab-animal 2016
American journal of translational research ·doi:10.22029/jlupub-8634

In the endometrium transforming growth factor-betas (TGF-βs) are involved mainly in menstruation and endometriosis. After binding of the ligands to the high-affinity receptors, TGF-β receptors (TBR1 and TBR2), TGF-βs activate Smad signaling…

2016
lab-animal 2015
·doi:10.17950/ijset/v4s12/1205

Transforming growth factor-betas (TGF-βs) are elevated during menstruation and are involved in endometriosis. Similarly, matrix metalloproteinases like MMP-2 are also highly expressed in patients with endometriosis. Expression of gelatinase…

2014
·doi:10.1007/978-4-431-54421-0_21
other 2011
Archives of gynecology and obstetrics ·doi:10.1007/s00404-010-1819-0

PURPOSE: To determine whether a structured questionnaire can improve preoperative assessment of patients with endometriosis. METHODS: Hospital records for patients with endometriosis were evaluated retrospectively to determine the complete…

lab-animal 2011
·doi:10.1055/s-0031-1280498

Objectives: In clinical trials, transforming growth factor betas (TGF-betas) and plasminogen activator inhibitor-1 (PAI-1) were observed to be highly expressed at endometriotic sites as well as in the peritoneal fluid or serum of patients w…

2010
2010
·doi:10.5301/je.2010.6207
observational 2010
·doi:10.1177/228402651000200405

Background Deep infiltrating endometriosis (DIE) in contrast to superficial endometriosis is known to cause intense pain-related symptoms depending on the anatomic region and depth of infiltration. Despite the known impact of DIE, clinical …

observational 2009
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513590903159607

Endometriosis affects 6-10% of women in reproductive age, 35-50% of whom experience pain, infertility or both. Mild cases are managed medically but surgery provides relief to women in pain. However, symptoms recur in 75% of cases within 2 y…

2009
·doi:10.1080/09513590903159607
review 2009
Human Reproduction ·doi:10.1093/humrep/dep382

Endometriosis is characterized by presence of endometrial tissue outside the uterus. Prevalence is estimated at 6-10% in the general female population and many patients experience pain and/or infertility. Diagnosis is achieved by laparoscop…